Skip to content

Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Gas Permeable Contact Lens Wearers

Clinical Evaluation of the Safety and Efficacy of FID 120947A Compared to a Marketed Lens Care Solution in Gas Permeable Contact Lens Wearers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01912781
Enrollment
112
Registered
2013-07-31
Start date
2013-11-30
Completion date
2014-05-31
Last updated
2015-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Astigmatism, Hyperopia, Refractive Error

Keywords

contact lenses, contact lens solution, gas permeable contact lenses

Brief summary

The purpose of this study is demonstrate substantial equivalence of an investigational contact lens disinfecting solution to a commercially available contact lens solution in gas permeable lens wearers.

Detailed description

Subjects with normal eyes (other than correction for refractive error) successfully wearing silicone acrylate or fluoro silicone acrylate gas permeable contact lenses were randomized 2:1 to receive either the investigational or commercial contact lens solution for daily use throughout the study (90 days).

Interventions

Investigational 3% hydrogen peroxide solution intended for simultaneous cleaning, protein removal, disinfecting and storage of gas permeable contact lenses

DEVICEBoston Simplus multi-action solution

Commercially available solution indicated for cleaning, removing protein, rinsing, disinfecting, conditioning, storing and cushioning of fluoro silicone acrylate and silicone acrylate rigid gas permeable contact lenses

DEVICEGas permeable contact lenses

Commercially available gas permeable contact lenses worn a minimum of 8 hours each day on a daily wear basis for the duration of the study (90 days).

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Normal eyes (other than correction for visual acuity); * Successful history of gas permeable contact lens wear in both eyes in one of two brands: Boston XO or Boston II; * Best spectacle corrected distance visual acuity greater than or equal to 20/25 in each eye; * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Any ocular or systemic medical condition that may, in the opinion of the investigator, preclude safe administration of the investigational products or affect the results of this study; * Need to wear contact lenses on an extended wear basis (ie, overnight) during the study; * Use of a daily cleaner and/or an enzyme cleaner to care for lenses at least 7 days prior to Visit 1; * History of intolerance or hypersensitivity to any component of the investigational products; * Use of all over-the-counter (OTC) or prescribed topical ocular medications within 7 days prior to Visit 1; * Moderate, severe, abnormal, or other ocular findings; * Current or history of ocular infection, severe inflammation, or disease within 6 months prior to Visit 1; * Any systemic disease at Visit 1 (including allergies, respiratory infections or colds) that may affect the eye or be exacerbated by use of contact lenses or contact lens solutions; * Use of systemic medications that may contribute to adverse ocular effects unless on a stable dosing regimen; * Ocular surgery within the last 12 months; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Subjects With Visibly Clean LensesDay 7, Day 30, Day 60, Day 90Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. A lens was considered visibly clean if it had nondetectable films or deposits. One eye (study eye) contributed to the analysis.
Percentage of Subjects With Crystalline Deposits by TypeDay 7, Day 30, Day 60, Day 90Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered: Type II = films or deposits visible only under special conditions, such as special illumination using an eyepiece of 7-10 times magnification, Type III = films or deposits readily visible on a dry lens under room lighting, with unaided eye, and Type IV = films or deposits obvious under room lighting, with unaided eye, when the lens is wet or dry. One eye (study eye) contributed to the analysis.
Percentage of Subjects With Film Deposits by TypeDay 7, Day 30, Day 60, Day 90Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered: Type II = films or deposits visible only under special conditions, such as special illumination using an eyepiece of 7-10 times magnification, Type III = films or deposits readily visible on a dry lens under room lighting, with unaided eye, and Type IV = films or deposits obvious under room lighting, with unaided eye, when the lens is wet or dry. One eye (study eye) contributed to the analysis.
Average Residual Lens LysozymeDay 90/Early ExitWorn study lenses were removed and analyzed by high performance liquid chromatography (HPLC) for residual lens lysozyme (protein). Values reported as lower than the limit of quantitation or none detected were imputed as 0.5 μg or 0 μg, respectively. A lower value indicates less lysozyme deposition. One eye (study eye) contributed to the analysis.
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeBaseline (Day 0), Day 7, Day 30, Day 60, Day 90Distance VA was assessed for each eye individually while reading a chart distant to the participant in dimmed room illumination. VA was measured using a Snellen chart, with 20/20 Snellen acuity considered normal distance-eyesight. A line increase indicates an improvement in VA. One eye (study eye) contributed to the analysis.
Average Lens Wear TimeDay 7, Day 30, Day 60, Day 90Subject recorded a response to the question, Averaging over the last 3 days, how many hours per day did you wear your contact lenses? Lens wear time was measured in hours.
Number of Unscheduled Lens Replacements by ReasonUp to Day 90No lens replacements were planned during the study. Lenses could be replaced as needed due to loss, damage, or as deemed necessary by the Investigator. If it became necessary to replace a lens, the subject was examined at an unscheduled visit. The counts in the table represent the total number of unscheduled lenses replaced by reason for any eye, any subject.
Likert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Day 30, Day 60, Day 90Lens comfort was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.
Likert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Day 30, Day 60, Day 90Clear vision was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.
Likert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Day 30, Day 60, Day 90Product handling was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.
Crystalline Deposit Area CoveredDay 7, Day 30, Day 60, Day 90Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. Values were reported as a percentage of lens area covered. One eye (study eye) contributed to the analysis.
Film Deposit Area CoveredDay 7, Day 30, Day 60, Day 90Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. Values were reported as a percentage of lens area covered. One eye (study eye) contributed to the analysis.

Participant flow

Recruitment details

Subjects were recruited from 12 study centers located in the US.

Pre-assignment details

Of the 112 enrolled, 2 subjects were exited as screen failures and 4 were discontinued prior to randomization. This reporting group includes all randomized subjects (106).

Participants by arm

ArmCount
FID 120974A
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
71
Boston Simplus
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
35
Total106

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicFID 120974ABoston SimplusTotal
Age, Continuous52.9 years
STANDARD_DEVIATION 10.2
50.5 years
STANDARD_DEVIATION 13.4
52.1 years
STANDARD_DEVIATION 11.4
Sex: Female, Male
Female
55 Participants28 Participants83 Participants
Sex: Female, Male
Male
16 Participants7 Participants23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 1120 / 710 / 35
serious
Total, serious adverse events
0 / 1120 / 710 / 35

Outcome results

Primary

Average Lens Wear Time

Subject recorded a response to the question, Averaging over the last 3 days, how many hours per day did you wear your contact lenses? Lens wear time was measured in hours.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

ArmMeasureGroupValue (MEAN)Dispersion
FID 120974AAverage Lens Wear TimeDay 712.3 HoursStandard Deviation 2.7
FID 120974AAverage Lens Wear TimeDay 6011.8 HoursStandard Deviation 2.9
FID 120974AAverage Lens Wear TimeDay 9012.4 HoursStandard Deviation 2.8
FID 120974AAverage Lens Wear TimeDay 3012.5 HoursStandard Deviation 2.7
Boston SimplusAverage Lens Wear TimeDay 9013.1 HoursStandard Deviation 2.6
Boston SimplusAverage Lens Wear TimeDay 713.3 HoursStandard Deviation 2.4
Boston SimplusAverage Lens Wear TimeDay 3012.7 HoursStandard Deviation 2.8
Boston SimplusAverage Lens Wear TimeDay 6013.3 HoursStandard Deviation 2.6
Primary

Average Residual Lens Lysozyme

Worn study lenses were removed and analyzed by high performance liquid chromatography (HPLC) for residual lens lysozyme (protein). Values reported as lower than the limit of quantitation or none detected were imputed as 0.5 μg or 0 μg, respectively. A lower value indicates less lysozyme deposition. One eye (study eye) contributed to the analysis.

Time frame: Day 90/Early Exit

Population: This analysis population includes all randomized subjects.

ArmMeasureValue (MEAN)Dispersion
FID 120974AAverage Residual Lens Lysozyme0.2 micrograms per lensStandard Deviation 0.5
Boston SimplusAverage Residual Lens Lysozyme0.2 micrograms per lensStandard Deviation 0.4
Primary

Crystalline Deposit Area Covered

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. Values were reported as a percentage of lens area covered. One eye (study eye) contributed to the analysis.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all randomized subjects. Here, n is the total number of subjects with crystalline deposits in each treatment group, respectively, by visit.

ArmMeasureGroupValue (MEAN)Dispersion
FID 120974ACrystalline Deposit Area CoveredDay 7, n=10, 518.0 percentage of lens areaStandard Deviation 16.2
FID 120974ACrystalline Deposit Area CoveredDay 30, n=17, 313.6 percentage of lens areaStandard Deviation 18.1
FID 120974ACrystalline Deposit Area CoveredDay 60, n=18, 811.9 percentage of lens areaStandard Deviation 14.1
FID 120974ACrystalline Deposit Area CoveredDay 90, n=21, 1018.1 percentage of lens areaStandard Deviation 16.3
Boston SimplusCrystalline Deposit Area CoveredDay 90, n=21, 1010.8 percentage of lens areaStandard Deviation 14.5
Boston SimplusCrystalline Deposit Area CoveredDay 7, n=10, 519.0 percentage of lens areaStandard Deviation 18.2
Boston SimplusCrystalline Deposit Area CoveredDay 60, n=18, 87.0 percentage of lens areaStandard Deviation 3.5
Boston SimplusCrystalline Deposit Area CoveredDay 30, n=17, 316.7 percentage of lens areaStandard Deviation 20.2
Primary

Film Deposit Area Covered

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. Values were reported as a percentage of lens area covered. One eye (study eye) contributed to the analysis.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all randomized subjects. Here, n is the total number of subjects with film deposits in each treatment group, respectively, by visit.

ArmMeasureGroupValue (MEAN)Dispersion
FID 120974AFilm Deposit Area CoveredDay 7, n=40, 1523.8 percentage of lens areaStandard Deviation 17.2
FID 120974AFilm Deposit Area CoveredDay 30, n=47, 2026.2 percentage of lens areaStandard Deviation 22
FID 120974AFilm Deposit Area CoveredDay 60, n=47, 2026.4 percentage of lens areaStandard Deviation 17.5
FID 120974AFilm Deposit Area CoveredDay 90, n=45, 2425.3 percentage of lens areaStandard Deviation 13.7
Boston SimplusFilm Deposit Area CoveredDay 90, n=45, 2428.3 percentage of lens areaStandard Deviation 21.9
Boston SimplusFilm Deposit Area CoveredDay 7, n=40, 1522.7 percentage of lens areaStandard Deviation 13.7
Boston SimplusFilm Deposit Area CoveredDay 60, n=47, 2024.0 percentage of lens areaStandard Deviation 11
Boston SimplusFilm Deposit Area CoveredDay 30, n=47, 2028.4 percentage of lens areaStandard Deviation 21.1
Primary

Likert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.

Clear vision was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

ArmMeasureGroupValue (NUMBER)
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Strongly Agree37.7 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Agree40.6 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Undecided2.9 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Disagree15.9 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Strongly Disagree2.9 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Strongly Agree29.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Agree53.6 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Undecided7.2 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Disagree10.1 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Strongly Disagree0.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Strongly Agree33.3 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Agree49.3 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Undecided4.3 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Disagree11.6 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Strongly Disagree1.4 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Strongly Agree29.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Agree49.3 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Undecided7.2 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Disagree13.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Strongly Disagree1.4 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Undecided5.7 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Strongly Agree48.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Strongly Agree57.1 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Agree45.7 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Strongly Agree45.7 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Undecided0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Agree28.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Disagree5.7 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Strongly Disagree0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 7, Strongly Disagree0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Undecided5.7 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Strongly Agree48.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Agree34.3 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Agree45.7 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Disagree8.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Undecided2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 90, Disagree14.3 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Disagree2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 60, Strongly Disagree0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear.Day 30, Strongly Disagree0.0 percentage of subjects
Primary

Likert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.

Product handling was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

ArmMeasureGroupValue (NUMBER)
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Strongly Agree23.2 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Agree50.7 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Undecided20.3 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Disagree5.8 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Strongly Disagree0.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Strongly Agree26.1 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Agree53.6 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Undecided13.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Disagree5.8 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Strongly Disagree1.4 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Strongly Agree26.1 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Agree56.5 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Undecided14.5 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Disagree2.9 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Strongly Disagree0.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Strongly Agree27.5 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Agree52.2 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Undecided11.6 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Disagree7.2 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Strongly Disagree1.4 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Undecided5.7 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Strongly Agree48.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Strongly Agree51.4 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Agree40.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Strongly Agree48.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Undecided8.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Agree34.3 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Disagree2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Strongly Disagree2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 7, Strongly Disagree0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Undecided11.4 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Strongly Agree57.1 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Agree40.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Agree34.3 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Disagree0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Undecided8.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 90, Disagree2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Disagree0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 60, Strongly Disagree2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, I Like the Way This Product Feels During Handling.Day 30, Strongly Disagree0.0 percentage of subjects
Primary

Likert Item - When I Use This Solution, my Lenses Are Comfortable All Day.

Lens comfort was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

ArmMeasureGroupValue (NUMBER)
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Strongly Agree30.4 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Agree52.2 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Undecided7.2 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Disagree10.1 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Strongly Disgree0.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Strongly Agree31.9 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Agree47.8 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Undecided4.3 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Disagree13.0 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Strongly Disagree2.9 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Strongly Agree30.4 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Agree49.3 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Undecided8.7 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Disagree10.1 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Strongly Disagree1.4 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Strongly Agree30.4 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Agree50.7 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Undecided1.4 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Disagree15.9 percentage of subjects
FID 120974ALikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Strongly Disagree1.4 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Undecided2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Strongly Agree68.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Strongly Agree62.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Agree28.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Strongly Agree54.3 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Undecided0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Agree28.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Disagree2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Strongly Disagree2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 7, Strongly Disgree0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Undecided0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Strongly Agree68.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Agree28.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Agree28.6 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Disagree5.7 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Undecided2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 90, Disagree11.4 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Disagree0.0 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 60, Strongly Disagree2.9 percentage of subjects
Boston SimplusLikert Item - When I Use This Solution, my Lenses Are Comfortable All Day.Day 30, Strongly Disagree0.0 percentage of subjects
Primary

Number of Unscheduled Lens Replacements by Reason

No lens replacements were planned during the study. Lenses could be replaced as needed due to loss, damage, or as deemed necessary by the Investigator. If it became necessary to replace a lens, the subject was examined at an unscheduled visit. The counts in the table represent the total number of unscheduled lenses replaced by reason for any eye, any subject.

Time frame: Up to Day 90

Population: This analysis population includes all randomized subjects.

ArmMeasureGroupValue (NUMBER)
FID 120974ANumber of Unscheduled Lens Replacements by ReasonLost3 lenses
FID 120974ANumber of Unscheduled Lens Replacements by ReasonLens torn on eye0 lenses
FID 120974ANumber of Unscheduled Lens Replacements by ReasonLens torn while handling1 lenses
Boston SimplusNumber of Unscheduled Lens Replacements by ReasonLost1 lenses
Boston SimplusNumber of Unscheduled Lens Replacements by ReasonLens torn on eye1 lenses
Boston SimplusNumber of Unscheduled Lens Replacements by ReasonLens torn while handling0 lenses
Primary

Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change

Distance VA was assessed for each eye individually while reading a chart distant to the participant in dimmed room illumination. VA was measured using a Snellen chart, with 20/20 Snellen acuity considered normal distance-eyesight. A line increase indicates an improvement in VA. One eye (study eye) contributed to the analysis.

Time frame: Baseline (Day 0), Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

ArmMeasureGroupValue (NUMBER)
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, 2 Line Increase from Baseline0.0 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, 1 Line Increase from Baseline2.9 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, No Change from Baseline92.8 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, 1 Line Decrease from Baseline4.3 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, 2 Line Decrease from Baseline0.0 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, 2 Line Increase from Baseline0.0 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, 1 Line Increase from Baseline1.4 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, No Change from Baseline95.7 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, 1 Line Decrease from Baseline2.9 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, 2 Line Decrease from Baseline0.0 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, 2 Line Increase from Baseline1.4 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, 1 Line Increase from Baseline1.4 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, No Change from Baseline97.1 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, 1 Line Decrease from Baseline0.0 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, 2 Line Decrease from Baseline0.0 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, 2 Line Increase from Baseline0.0 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, 1 Line Increase from Baseline0.0 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, No Change from Baseline97.1 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, 1 Line Decrease from Baseline2.9 percentage of subjects
FID 120974APercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, 2 Line Decrease from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, No Change from Baseline91.4 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, 2 Line Increase from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, 2 Line Increase from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, 1 Line Increase from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, 2 Line Increase from Baseline2.9 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, No Change from Baseline94.3 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, 1 Line Increase from Baseline2.9 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, 1 Line Decrease from Baseline5.7 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, 2 Line Decrease from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 7, 2 Line Decrease from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, No Change from Baseline94.3 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, 2 Line Increase from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, 1 Line Increase from Baseline2.9 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, 1 Line Increase from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, 1 Line Decrease from Baseline2.9 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, No Change from Baseline97.1 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 90, 1 Line Decrease from Baseline2.9 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, 1 Line Decrease from Baseline2.9 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 60, 2 Line Decrease from Baseline0.0 percentage of subjects
Boston SimplusPercentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line ChangeDay 30, 2 Line Decrease from Baseline0.0 percentage of subjects
Primary

Percentage of Subjects With Crystalline Deposits by Type

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered: Type II = films or deposits visible only under special conditions, such as special illumination using an eyepiece of 7-10 times magnification, Type III = films or deposits readily visible on a dry lens under room lighting, with unaided eye, and Type IV = films or deposits obvious under room lighting, with unaided eye, when the lens is wet or dry. One eye (study eye) contributed to the analysis.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all randomized subjects. Here, n is the total number of subjects with crystalline deposits in each treatment group, respectively, by visit.

ArmMeasureGroupValue (NUMBER)
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 7, Type II, n=10, 590.0 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 7, Type III, n=10, 50.0 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 7, Type IV, n=10, 510.0 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 30, Type II, n=17, 370.6 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 30, Type III, n=17, 317.6 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 30, Type IV, n=17, 311.8 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 60, Type II, n=18, 861.1 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 60, Type III, n=18, 816.7 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 60, Type IV, n=18, 822.2 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 90, Type II, n=21, 1061.9 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 90, Type III, n=21, 1023.8 percentage of subjects
FID 120974APercentage of Subjects With Crystalline Deposits by TypeDay 90, Type IV, n=21, 1014.3 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 90, Type III, n=21, 1010.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 7, Type II, n=10, 580.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 60, Type II, n=18, 887.5 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 7, Type III, n=10, 520.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 90, Type II, n=21, 1060.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 7, Type IV, n=10, 50.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 60, Type III, n=18, 80.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 30, Type II, n=17, 3100.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 90, Type IV, n=21, 1030.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 30, Type III, n=17, 30.0 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 60, Type IV, n=18, 812.5 percentage of subjects
Boston SimplusPercentage of Subjects With Crystalline Deposits by TypeDay 30, Type IV, n=17, 30.0 percentage of subjects
Primary

Percentage of Subjects With Film Deposits by Type

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered: Type II = films or deposits visible only under special conditions, such as special illumination using an eyepiece of 7-10 times magnification, Type III = films or deposits readily visible on a dry lens under room lighting, with unaided eye, and Type IV = films or deposits obvious under room lighting, with unaided eye, when the lens is wet or dry. One eye (study eye) contributed to the analysis.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all randomized subjects. Here, n is the total number of subjects with film deposits in each treatment group, respectively, by visit.

ArmMeasureGroupValue (NUMBER)
FID 120974APercentage of Subjects With Film Deposits by TypeDay 7, Type II, n=40, 1580.0 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 7, Type III, n=40, 157.5 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 7, Type IV, n=40, 1512.5 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 30, Type II, n=47, 2072.3 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 30, Type III, n=47, 2010.6 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 30, Type IV, n=47, 2017.0 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 60, Type II, n=47, 2074.5 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 60, Type III, n=47, 2021.3 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 60, Type IV, n=47, 204.3 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 90, Type II, n=45, 2473.3 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 90, Type III, n=45, 2413.3 percentage of subjects
FID 120974APercentage of Subjects With Film Deposits by TypeDay 90, Type IV, n=45, 2413.3 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 90, Type III, n=45, 248.3 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 7, Type II, n=40, 1566.7 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 60, Type II, n=47, 2080.0 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 7, Type III, n=40, 1526.7 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 90, Type II, n=45, 2479.2 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 7, Type IV, n=40, 156.7 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 60, Type III, n=47, 205.0 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 30, Type II, n=47, 2080.0 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 90, Type IV, n=45, 2412.5 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 30, Type III, n=47, 2010.0 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 60, Type IV, n=47, 2015.0 percentage of subjects
Boston SimplusPercentage of Subjects With Film Deposits by TypeDay 30, Type IV, n=47, 2010.0 percentage of subjects
Primary

Percentage of Subjects With Visibly Clean Lenses

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. A lens was considered visibly clean if it had nondetectable films or deposits. One eye (study eye) contributed to the analysis.

Time frame: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

ArmMeasureGroupValue (NUMBER)
FID 120974APercentage of Subjects With Visibly Clean LensesDay 3029.0 percentage of subjects
FID 120974APercentage of Subjects With Visibly Clean LensesDay 6029.0 percentage of subjects
FID 120974APercentage of Subjects With Visibly Clean LensesDay 9030.4 percentage of subjects
FID 120974APercentage of Subjects With Visibly Clean LensesDay 742.0 percentage of subjects
Boston SimplusPercentage of Subjects With Visibly Clean LensesDay 9031.4 percentage of subjects
Boston SimplusPercentage of Subjects With Visibly Clean LensesDay 6042.9 percentage of subjects
Boston SimplusPercentage of Subjects With Visibly Clean LensesDay 757.1 percentage of subjects
Boston SimplusPercentage of Subjects With Visibly Clean LensesDay 3042.9 percentage of subjects

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026